58
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Mutational Analyses of the AML1 Gene in Patients with Myelodysplastic Syndrome

, , , , , , , & show all
Pages 617-621 | Published online: 01 Jul 2009

  • Bae, S.C., Yamaguchi-Iwai, Y., Ogawa, E., Maruyama, M., Inuzuka, M., Kagoshima, H., Shigesada, K., Satake, M. and Ito. Y (1993) "Isolation of PEBP2aB cDNA representing the mouse homolog of human acute myeloid leukemia gene. AML", Oncogent 8, 809-814.
  • Hirai, H., Kobayashi. Y. Mano. H., Hagiwara, K., Maru, Y., Omine, M., Mizoguchi, H., Nishida, J. and Takaku, F. (1987) "A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome", Nature 327, 430-432.
  • Hirai, H., Okada. M., Mizoguchi, H., Mano. H., Kobayashi. Y, Nishida. J. und Takaku. F. (1988) "Relationship between an activated N-ras oncogene and chromosomal abnormality during leukemk progression from myelodysplastic syndrome", Blood 71, 256-258.
  • Tanaka, T., Milani. K., Kurokawa, M., Ogawa, S., Tanaka, K., Nishida, J., Yazaki, Y. Shibata, Y. and Hirai, H. (1995) "Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3:21) leukemias", Mol. Cell. Biol. 15, 2383-2392.
  • Nuchpruyoon, I., Meyers, S., Scott, L.M., Suzow, J., Hiebert, S. and Friedman, A.D. (1994) "PEBP2/CBF, the murine homolog of the human myeloid AMLl and PEBP2ß/CBHß proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells", Mol. Cell. Biol. 14, 5558-5568.
  • Zhang, D.E., Fujioka. K., Hetherington. C.J., Shapiro. L.H., Chen, H.M., Look, A.T. and Tenen, O.G. (1994) "Identification of aregion which directs the inonocytic activity of the colony-stimulating factor I (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AMIJ)", Mol. Cell. Biol. 14, 8085-8095.
  • Zhang, D.E., Hetherington, C.J., Meyers S., Rhoades. K.I., Larson, C.J, Chen, H.M., Hiebert, S.W. and Tenen, O.G. (1996) "CCAAT enhancer-binding protein (C/EBP) and AML1 (CBFa2) synergistically activate the macrophage colony-stimulating factor receptor promoter", Mol. Cell. Hint. 16, 1231-1240.
  • Takahashi, A., Satake, M., Yarnaguchi-Iwai, Y. Bac, S.C., Lu, J., Maruyama, M., Zhang, Y.W., Oka, H., Arai, N. and Anu, K. (1995) "Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AMLI-related transcription factor PEBP2", Blood 86, 607-616.
  • Giese, K., Kingsley, C., Kirshner. J.R. and Grosschedl, R. (1995) "Assembly and function of a TCR á enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions", Genes Dev. 9, 995-1008.
  • Hernandez-Munain, C. and Krangel, M.S. (1995) "c-Myb and corebinding factor/PFBP2 display functional synergy but bind independently to adjacent site* in the T-cell receptor ä enhancer", Mol. Cell. Biol. 15, 3090-3099.
  • Sun, W., Graves, B.J. and Speck, N.A. (1995) "Tranxactivation of the Moloney murinc leukemia virus and T-cell receptor â chain enhancers by cbf and els requires intact binding sites for both proteins", J. Virol. 69, 4941-4949.
  • Kurokawa, M., Tanaka, T., Tanaka, K., Ogawa, S., Mitani, K., Yazaki, Y and Hirai, H. (1996) "Overexpression of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies", Oncogene 12, 883-892.
  • Ogawa, F., Maruyama, M., Kagoshima, H., Inuzuka, M., Lu. J., Satake, M., Shigesada, K. and Ito, Y. (1993) "PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drsophila runt gene and the human AMLI gene", Proc. Natl Acad. Sci. USA 90, 6859-6863.
  • Miyoshi, H., Ohira, M., Shimizu. K., Mitani, K., Hirai, H., lmai, T., Yokoyama, K., Socda, E. and Ohki, M. (1995) "Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia", Nucl. Acids Res. 23, 2762-2769.
  • Niki, M., Okada, H., Takano, H., Kuno, J., Tani, K., Hibino, H., Asano, S., Ito, Y., Satake, M. and Noda, T. (1997) "Hematopoiesis in the fetal liver is impaired by targeted mulagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor", Proc. Natl. Acad. Sci, USA 94, 5697-5702.
  • Okuda, T., van Deursen, J., Hieben, S.W., Grosveld, G., and Downing, J.R. (1996) "AMLI, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis", Cell 84, 321-330.
  • Ohki, M. (1993) "Molecular basis of the t(8;21) translocation in acute myeloid leukaemia", Semin. Cancer Biol. 4, 369-375.
  • Miyoshi, H., Shimizu, K., Kara, T., Maseki, N., Kaneko, Y. and Ohki, M. (1991) "t(8;2I) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AMLI", Proc. Natl. Acad. Sci. USA 88, 10431-10434.
  • Miyoshi, H., Kozu, T., Shimizu, K., Enomoto, K., Maseki, N., Kaneko, Y., Kamada, N. and Ohki, M. (1993) 'The t(8:21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript", EMBO J. 12, 2715-2721.
  • Erickson, P., Gao, J., Chang, K.S., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J. and Drabkin, H. (1992) "Identification of breakpoints in 1(8:21) acute myelogenous leukemia and isolation of a fusion transcript, AMLI/ETO, with similarity to Drosophila segmentation gene, runt", Blood 80, 1825 1831.
  • Erickson, P.K, Robinson, M., Owens, G. and Drabkin, H.A. (1994) 'The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionary conserved, putative transcription factor", Cancer Res. 54, 1782-1786.
  • Mitani, K., Ogawa, S., Tanaka, T., Miyoshi, H., Kurokawa, M., Mano, H., Yazaki, Y. Ohki, M. and Hirai, H. (1994) "Generation of the AML1-Evi-1 fusion gene in the t(3:21)(q26;q22) causes blastic crisis in chronic myclocytic leukemia", EMBO J. 13, 504-510.
  • Nucifora, G., Begy, C.R., Erickson, P., Drabkin, H.A. and Rowley, J.D. (1993) "The (3:21) translocation in myelndysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1", Proc. Natl Acad Sci. USA 90, 7784-7788.
  • Nucifora, G., Birn, D.J., Espinosa, R.D., Erickson, P., LeBeau, M.M., Roulston, D., McKeithan, T.W., Drabkin, H. and Rowley, J.D. (1993) "Involvement of the AML1 gene in the t(3:21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis", Blood 81, 2728-2734.
  • Nucifora, G. and Rowley, J.D. (1994) "The AMLl gene in the (8;21) and (3;21) translocations in chronic and acute myeloid leukemia", Cold Spring Harb. Simp. Quant. Biol. 59, 595-605.
  • Nucifora, G. and Rowley, J.D. (1995) "AML1 and the (8;21) and (3;21) translocations in acute and chronic myeloid leukemia", Blood 86, 1-14.
  • Liu, P., Tarle, S.A., Hajra, A., Claxton, D.F., Marlton, P., Freedman, M., Siciliano, M.J. and Collins, F.S. (1993) "Fusion between transcription factor CBFß/PEBP2ß and a myosin heavy chain in acute myeloid leukemia", Science 261, 1041-1044.
  • Osato, M., Asou, N., Abdalla, E., Hoshino, K., Yamasaki, H., Okubo, T., Suzushima, H., Takatsuki, K., Kanno, T., Shigesada, K. and lto, Y. (1999) "Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2aB gene associated with myelioblastic leukemias", Blood 93, 1817-1824.
  • Preudhomme, C., Warot-Loze, D., Roumier, C., Grardel Duflos, N., Garand, R., Lai, J.L., Dastugue, N., Macintyre, E., Denis. C., Earners, F., Kerekaert, J.P., Cosson, A. and Fenaux, P. (2000) "High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2aB gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21", Blood 96. 2862-2869.
  • Song, W.J., Sullivan, M.G., Legare, R.D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I.C., Haworth, C., Hock, R., Lob, M., Felix, C., Roy, D.C., Busque, L., Kurnit, D., Willman, C., Gewirtz, A.M., Speck, N.A., Bushweller, J.H., Li, F.P., Gardiner, K., Ponez, M., Maris, J.M. and GiIIiland, D.G. (1999) "Haploinsufficiency of CBFA2 causes familial thrombocytupenia with propesity to develop acute myelogenous leukaemia", Nat. Genet, 23, 166-175.
  • Imai, Y., Kurokawa, M., Izutsu, K., Hangaishi, A., Takeuchi, K., Maki. K., Ogawa, S., Chiba, S., Mitani, K. and Hirai, H. (2000) "Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukcmogenesis", Blood 96, 3154-3160.
  • Frank, R., Zhang, J., Uchida, H., Meyers, S., Hiebert, S.W. and Nimer, S.D. (1995) 'The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AMLIB", Oncogene 11, 2667-2674.
  • Meyers, S., Downing, J.R. and Hiebert, S.W. (1993) "Identification of AML-1 and the (8:21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required or DNA binding and protein-protein interactions", Mol. Cell Biol. 13, 6336-6345.
  • Meyers, S., Lenny, N. and Hiebert, S.W. (1995) "The t(8;21) fusion protein interferes with AML-IB-dependent transcriptional activation", Mol. Cell. Biol. 15, 1974-1982.
  • Meyers, S., Lenny, N., Sun, W. and Hiebert, S.W. (1996) "AML-2 is a potential target for transcriptional regulation by the t(8:21) and t(12:21) fusion proteins in acute leukemia", Oncogene 13, 303-312.
  • Tanaka, T., Tanaka, K., Ogawa, S., Kurokawa, M, Mitani, K., Nishida, J., Shibata, Y., Yazaki, Y. and Hirai, H. (1995) "An acute myeloid leukemia gene AML1, regulates hemopoietic myeloid cell differentiation and trarscriptional activation antagonistically by two alternative spliced forms", EMBO J. 14, 341-350.
  • Ogawa, E. Inuzuka, M., Maruyama, M., Satake, M., Naito Fujimoto, M., Ito. Y and Shigesada, K. (1993) "Molecular cloning and characterization of PEBP2a, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2a", Virology 194, 314-331.
  • Huang, G., Shigesada, X., Ito, K., Wee, H.J., Yokomizo, T. and Ito, Y. (2001) "Dimerization with PKBH2ß protects RUNX1/AML1 from ubiquitin-pfoteasome-mediated degradation", EMBO J. 20, 723 733.
  • Tanaka, K., Tanaka, T., Kurokawa, M., Imai, Y, Ogawa, S., Mitani, K., Yazaki, Y and Hirai, H. (1998) "The AML1/ETO(MTG8) and AMLl/Evi-1 leukemia-associated chimeric oncoproteins accumulate PEBP2ß (CBFß) in the nucleus more efficiently than wild-type AML1", Blood 91, 1688-1699.
  • Tahirov, T.H., Inoue-Bungo, T., Morii, H., Fujikawa, A., Sasaki, M., Kimura, K., Shiina, M., Sato, K., Kumasaka, T., Yamamoto, M., Ishii, S. and Ogata, K. (2001) "Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFß", Cell 104, 755-767.
  • Nagata, T. and Werner, M.H. (2001) "Functional mutagenesis of AML1/RUNX1 and PEBP2ß/CBFß define distinct, non-overlapping sites for DNA recognition and heterodimerization by the Runt domain", J. Mol. Biol. 308, 191-203.
  • Okuda, T., Cai, Z., Yang, S., Lenny, N., Lyu, C.J., van Deursen, J.M., Harada, H. and Downing, J.R. (1998) "Expression of a knoeked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors", Blood 91, 3134-3143.
  • Rhoades, KL., Hetherington, C.J., Harakawa, N., Yergeau, D.A., Zhou, L., Liu. L.Q., Little, M.T., Tenen, D.G. and Zhang, D.E. (2000) "Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model", Blood 96, 2108-2115.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.